| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.46 | 4e-10 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.31 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.27 | 7e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.31 | 6e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |